These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16859748)

  • 1. Monoamine oxidase and tobacco dependence.
    Lewis A; Miller JH; Lea RA
    Neurotoxicology; 2007 Jan; 28(1):182-95. PubMed ID: 16859748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
    Rose JE; Behm FM; Ramsey C; Ritchie JC
    Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction.
    van Amsterdam J; Talhout R; Vleeming W; Opperhuizen A
    Life Sci; 2006 Oct; 79(21):1969-73. PubMed ID: 16884739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.
    Guillem K; Vouillac C; Azar MR; Parsons LH; Koob GF; Cador M; Stinus L
    Eur J Neurosci; 2006 Dec; 24(12):3532-40. PubMed ID: 17229101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking and nicotine dependence.
    Zbikowski SM; Swan GE; McClure JB
    Med Clin North Am; 2004 Nov; 88(6):1453-65, x. PubMed ID: 15464107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of nicotine and cigarette smoke on the monoamine transporters.
    Danielson K; Truman P; Kivell BM
    Synapse; 2011 Sep; 65(9):866-79. PubMed ID: 21308797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase B in the brains of smokers.
    Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Shea C; Schlyer D; Wolf AP; Warner D; Zezulkova I; Cilento R
    Nature; 1996 Feb; 379(6567):733-6. PubMed ID: 8602220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibition for tobacco pharmacotherapy.
    George TP; Weinberger AH
    Clin Pharmacol Ther; 2008 Apr; 83(4):619-21. PubMed ID: 18091758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Why nicotine cannot help with weaning from tobacco].
    Nau JY
    Rev Med Suisse; 2009 Jan; 5(187):218. PubMed ID: 19271434
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genetic aspects of smoking and impact on clinical care].
    Dobrinas M; Cornuz J; Kohler Serra M; Puhl M; Eap CB
    Rev Med Suisse; 2009 Jul; 5(210):1463-7. PubMed ID: 19634532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological aspects of the link between smoking and depression.
    Quattrocki E; Baird A; Yurgelun-Todd D
    Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptors and stages of nicotine dependence.
    Brennan KA; Lea RA; Fitzmaurice PS; Truman P
    J Psychopharmacol; 2010 Jun; 24(6):793-808. PubMed ID: 19251827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for tobacco dependence.
    Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
    Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidases and tobacco smoking.
    Berlin I; Anthenelli RM
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):33-42. PubMed ID: 11343627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence.
    Prasopthum A; Pouyfung P; Sarapusit S; Srisook E; Rongnoparut P
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):174-81. PubMed ID: 25857233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke.
    Hong SW; Teesdale-Spittle P; Page R; Truman P
    Neurotoxicology; 2022 Dec; 93():163-172. PubMed ID: 36155069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.
    Hutchison KE; Allen DL; Filbey FM; Jepson C; Lerman C; Benowitz NL; Stitzel J; Bryan A; McGeary J; Haughey HM
    Arch Gen Psychiatry; 2007 Sep; 64(9):1078-86. PubMed ID: 17768273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
    Castagnoli K; Murugesan T
    Neurotoxicology; 2004 Jan; 25(1-2):279-91. PubMed ID: 14697903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.